Clinical Trial

NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2023 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, single-center clinical trial in eccentric nasopharyngeal carcinoma (NPC) patients. The aim of this study is to evaluate the efficacy and safety of NBI combined with MRI-guided optimized CTV compared with conventional CTV, and to compare the radiotherapy-related adverse events and quality of life between the two groups.
Trial Details
NCT Number NCT06167109
Lead Sponsor Chongqing University Cancer Hospital
Conditions Nasopharyngeal Carcinoma by AJCC V8 Stage
Enrollment 60 participants
Start Date 2023-10-20
Primary Completion 2026-05 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-12-12